With regards to the Phase 2 trial in patients with Relapsed / Refractory AML (Investigator Sponsored Study in Israel) and since there is nothing else Clinical to get excited about at the moment.
As per the last Quarterly , Clinical programs update :
RI-002 Phase 2 trial in patients with Relapsed / Refractory AML (Investigator Sponsored Study in Israel): The Simon 2 stage design study has progressed to the Phase 2 efficacy (expansion) stage. Three patients have completed treatment in the Phase 2 stage. Results will be reported after 9 patients have completed treatment
In the trial design announcement :
Phase 2, Expansion (Efficacy Stage)
- Up to 17 subjects will be enrolled into a Phase 2 expansion efficacy cohort using a 2-stage Simon design.
- Initially, 9 subjects will be enrolled and treated with the recommended dose of FluCloZan regimen determined in Stage 1.
- If no subject responds according to the response criteria outlined in the European Leukemia Net (ELN) guidelines, in the first 9 subjects, the study will be terminated for futility.
- If at least one subject shows a response, 8 more subjects will be enrolled and treated. If three or more of subjects treated in Stage 2 respond, the null hypothesis can be rejected.
Since the Quarterly says 3 patients were recruited , does that mean that the first patient has showed a response and therefore the recruitment continued ?
And since 3 patients have been recruited and Sheba is still continuing the trial , would that mean that the results in those 3 patients have been positive so far to warrant the trial being continued ?
General Comments / Chat, page-8080
-
- There are more pages in this discussion • 3,011 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M |
Open | High | Low | Value | Volume |
$1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9998 | $1.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9998 | 1.750 |
1 | 7599 | 1.730 |
1 | 581 | 1.720 |
3 | 11557 | 1.710 |
4 | 46280 | 1.700 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 2000 | 1 |
1.830 | 44030 | 2 |
1.840 | 10500 | 2 |
1.850 | 14500 | 3 |
1.860 | 949 | 2 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |